Corporate News – Market Update
Adlai Nortye (ANL)
- 24‑hour performance: ↑ 5.83 % ending 08:34 PM CET, Thursday 22 June 2026.
- Current price: USD 10.87 per share on major exchanges.
- Shares outstanding: 58.7 million.
- Market capitalization: USD 719.6 million.
- Trading volume (last 24 h): USD 6 million.
- Month‑to‑month change: ↓ 32.17 % since the end of May.
- 200‑day simple moving average: USD 11.08.
- 52‑week range: High = USD 17.25 (21 April 2026); Low = USD 0.88 (9 December 2025).
Comparative Performance of Related Stocks (last 24 h)
| Symbol | 24‑hour change | Current price | Market cap | P/E ratio (where available) |
|---|---|---|---|---|
| Horizon Fixture (6957.TW) | – 3.66 % | TWD 455.5 | TWD 25.5 bn | – |
| Gem Services /Tw (6525.TW) | + 2.47 % | TWD 120.5 | TWD 16 bn | 17.32 |
| Hanchorbio (7827.TW) | – 3.83 % | TWD 149.5 | TWD 24.4 bn | – |
| Pcl (4977.TW) | + 5.56 % | TWD 170 | TWD 17.5 bn | 58.04 |
| Greenlight Capital Re (GLRE) | – 0.86 % | USD 15.38 | USD 491.9 mn | 10.06 |
Company Profile – Adlai Nortye Ltd.
Adlai Nortye Ltd. is a global clinical‑stage biotechnology firm focused on the discovery and development of innovative cancer therapies across multiple tumor types. The company conducts research and development activities aimed at advancing its therapeutic pipeline into clinical testing phases.
